Revisión
Revisión sistemática de los efectos adversos cutáneos causados por fármacos inhibidores de los puntos de control inmunitario: características, manejo y pronóstico
Characteristics, Management, and Prognostic Implications of Adverse Effects of Immune Checkpoint Inhibitors: A Systematic Review
G. Juan-Carpena
, J.C. Palazón-Cabanes, M. Blanes-Martínez
Servicio de Dermatología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, España
Leído
30819
Vecesse ha leído el artículo
4638
Total PDF
26181
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 11 | 235 | 21 | 256 |
| 2025 10 | 694 | 113 | 807 |
| 2025 9 | 393 | 58 | 451 |
| 2025 8 | 570 | 71 | 641 |
| 2025 7 | 734 | 115 | 849 |
| 2025 6 | 903 | 102 | 1005 |
| 2025 5 | 1221 | 107 | 1328 |
| 2025 4 | 1095 | 142 | 1237 |
| 2025 3 | 967 | 113 | 1080 |
| 2025 2 | 966 | 116 | 1082 |
| 2025 1 | 1048 | 103 | 1151 |
| 2024 12 | 816 | 96 | 912 |
| 2024 11 | 787 | 127 | 914 |
| 2024 10 | 758 | 118 | 876 |
| 2024 9 | 843 | 103 | 946 |
| 2024 8 | 730 | 98 | 828 |
| 2024 7 | 773 | 127 | 900 |
| 2024 6 | 769 | 122 | 891 |
| 2024 5 | 652 | 116 | 768 |
| 2024 4 | 493 | 87 | 580 |
| 2024 3 | 526 | 103 | 629 |
| 2024 2 | 540 | 90 | 630 |
| 2024 1 | 604 | 93 | 697 |
| 2023 12 | 360 | 60 | 420 |
| 2023 11 | 660 | 90 | 750 |
| 2023 10 | 497 | 71 | 568 |
| 2023 9 | 471 | 112 | 583 |
| 2023 8 | 437 | 60 | 497 |
| 2023 7 | 411 | 79 | 490 |
| 2023 6 | 467 | 103 | 570 |
| 2023 5 | 573 | 132 | 705 |
| 2023 4 | 403 | 86 | 489 |
| 2023 3 | 467 | 127 | 594 |
| 2023 2 | 310 | 107 | 417 |
| 2022 1 | 304 | 78 | 382 |
| 2022 12 | 1614 | 84 | 1698 |
| 2022 11 | 274 | 115 | 389 |
| 2022 10 | 249 | 120 | 369 |
| 2022 9 | 251 | 120 | 371 |
| 2022 8 | 201 | 92 | 293 |
| 2022 7 | 142 | 103 | 245 |
| 2022 6 | 248 | 180 | 428 |
| 2022 5 | 216 | 91 | 307 |
| 2022 4 | 145 | 76 | 221 |
| 2022 3 | 115 | 70 | 185 |
| 2022 2 | 102 | 46 | 148 |
| 2021 1 | 147 | 95 | 242 |
Mostrar todo
